Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.
Verywell Health on MSN
What you need to know about triple-negative breast cancer with chemo resistance
Medically reviewed by Marla Anderson, MD Key Takeaways Triple-negative breast cancer is aggressive and often resists ...
Triple Negative Breast Cancer (TNBC) is one of the most aggresive types of breast cancer. It’s the kind of breast cancer that doesn’t have estrogen receptors, progesterone receptors, and human ...
From left to right, Dr. Fernando Lecanda, Dr. Karmele Valencia, and Dr. Rafael Martínez Monge, from the Adhesion and Metastasis group at Cima, with Dr. Borja Ruiz-Fernández de Córdoba, also author of ...
Triple negative breast cancer (TNBC) represents approximately 10-15% of all breast cancer diagnoses but accounts for a disproportionately high percentage of breast cancer deaths. What sets this ...
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (EXAS), a leading provider of cancer screening and diagnostic tests, today announced the first clinical study results from its Oncodetect ® ...
Please provide your email address to receive an email when new articles are posted on . African American women with triple-negative breast cancer had similar tumor mutational landscape as white women ...
Hosted on MSN
New vaccine for aggressive breast cancer: Cleveland Clinic phase 1 trial results bring hope
Triple-negative breast cancer (TNBC) is widely regarded as one of the most aggressive and difficult, often deadly, forms of breast cancer. Unlike other subtypes, TNBC lacks oestrogen receptors (ER), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results